The global iron sucrose injection market is anticipated to grow at a CAGR of 6.8% during the forecast period (2022-2028). According to the WHO, the burden of anemia continues to be highest in the rest of the globe, with the Asia-Pacific being particularly hard hit, and to deal with this Iron Sucrose Injections are used to recover from anemia. Around 30% of the world’s population is anemic. Anemia occurs when the quantity of red blood cells or the concentration of hemoglobin within them is lower than usual.
Anemia is a severe global public health issue that disproportionately affects children under the age of five and pregnant women. According to the World Health Organization, 42% of children under the age of five and 40% of pregnant women are anemic globally. Taking iron orally or having iron supplied intravenously with vitamin C to recover from anemia is frequently the quickest way to raise iron levels. Iron is required for the production of hemoglobin in red blood cells, which enables RBCs to transport oxygen to organs and other bodily tissues. Therefore, the large patient base will help the market of Iron Sucrose Injection to grow in the anticipated period.
Alembic Pharmaceuticals Ltd. offers RICHAR CR 100MG 5ML AMP, It is used as an iron supplement that helps to prevent anemia, illness, vitamin deficiency due to a poor diet of iron. Elemental iron is used as a dietary supplement that helps the red blood cells to carry oxygen from the lungs to cells all over the body. Thereby reducing anemia.
The 50mg/2.5ml is generally given to pediatric patients and high doses like 100mg/5ml and 200mg/10ml are given to adult patients, in adult, anemia is major problems hence venofer iron sucrose demand is increasing Another factor for the growth of the market is that iron sucrose injections are used in the treatment of kidney diseases. Kidney disease affects an estimated 37 million people in the US, according to the National Kidney Foundation (15 percent of the adult population; more than 1 in 7 adults). Approximately 90% of people with renal disease are unaware that they have it. Women (14%) are more likely than men to have kidney disease (12 percent). However, three men’s kidneys fail for every two women who get end-stage kidney disease (ESKD). In the US, kidney disease is a primary cause of death. So the demand for Iron Sucrose Injection is going to increase in the forecasted period owing to an increase in the number of patients globally.
Some major players in the market include American Regent, Inc, Alkem Laboratories, Alembic Pharmaceuticals Ltd., Emcure Pharmaceuticals Ltd., Daiichi Sankyo Company Ltd. among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in April 2020 Daiichi Sankyo Altkirch SARL, a Daiichi Sankyo company with an Active Pharmaceutical Ingredient (API) pharmaceutical manufacturing plant in Altkirch, France, has acquired by American Regent, Inc., a U.S. manufacturer of pharmaceuticals for human and veterinary use with manufacturing sites in New York and Ohio.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Global Iron Sucrose Injection Market at https://orionmarketreports.com/request-sample/?id=94791&submit=Request+Sample%0D%0A
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Type
- By Application
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– American Regent, Inc, Alkem Laboratories, Alembic Pharmaceuticals Ltd., Emcure Pharmaceuticals Ltd., Daiichi Sankyo Company Ltd. among others.
A full report is available at: https://orionmarketreports.com/global-iron-sucrose-injection-market/94791/
Global Iron Sucrose Injection Market Report by Segment
By Type
- 50mg/2.5ml
- 100mg/5ml
- 200mg/10ml
By Application
- Anemia
- Kidney Disease
- Chronic Inflammatory Disease
- Others
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
